invent.
collaborate.
PROTECT.
Ricardo Moran, Ph.D.
PHONE:
(612) 767-4720
BIOGRAPHY
Ricardo J. Moran, Ph.D., is a highly experienced patent attorney with more than 25 years of experience helping life sciences and technology companies secure and maximize the value of their intellectual property. His practice focuses on patent preparation and prosecution, global portfolio strategy, and complex IP matters involving pharmaceuticals, biotechnology, immunology, and advanced chemical technologies. Dr. Moran advises multinational corporations, universities, and emerging companies on building and defending high-value patent portfolios, conducting freedom-to-operate analyses, and navigating strategic transactions. He brings a practical, business-oriented perspective shaped by in-house experience at GE Healthcare, where he worked alongside R&D, regulatory, and commercial teams on cutting-edge diagnostic technologies.
Dr. Moran has presented multiple webinars on key patent law topics, including obviousness-type double patenting and Section 101 patent eligibility, and is recognized for providing clear, strategic guidance on complex IP issues. Dr. Moran was also a faculty member at the AIPLA Patent Prosecution Boot Camp from 2024 to 2025. With a deep experience across the full patent lifecycle, he delivers strategic, commercially focused IP solutions aligned with clients’ innovation and growth objectives.
EDUCATION
- American University Washington College of Law
- J.D.
- University of Maryland
- Ph.D., Synthetic Organic Chemistry
- Emory University
- M.S., Synthetic Organic Chemistry
BAR ADMISSIONS
- Minnesota
- District of Columbia
- Federal District Court for the District of Columbia
- U.S. Patent and Trademark Office
Presentations
- Obviousness-type Double (ODP): From Zickendraht to Ex Parte Baurin and Beyond presented in house December 10, 2024
- Faculty at the 2024 AIPLA Patent Prosecution Bootcamp (Biotech/Pharma/Chemical) – San Jose, CA February 7-9, 2024
- Faculty at the 2025 AIPLA Patent Prosecution Bootcamp (Biotech/Pharma/Chemical) – Arlington, VA March 5-7, 2025
TECHNOLOGIES
- Small-molecule therapeutics
- Pharmaceutical formulations (including reformulations of existing drugs)
- Biotechnology and immunology
- Drug delivery systems
- Diagnostic imaging agents (including PET imaging technologies)
- Protein-based therapeutics (including anti-cancer technologies)
- Chemical materials and polymer science (including polyorganosiloxanes)
- Medical devices (including polymer-based devices)
- Biosensors and photochemistry
- Organometallic and synthetic organic chemistry
- Electronics and materials used in manufacturing (including LED technologies)
- Building products and industrial chemical applications
SERVICES
- Patent preparation and prosecution
- Global portfolio strategy
- Complex IP matters involving pharmaceuticals, biotechnology, immunology, and advanced chemical technologies
